First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients

Background/AimsAs previous real-world studies and meta-analyses have shown that mycophenolate mofetil (MMF) might have better efficacy than azathioprine (AZA) in autoimmune hepatitis (AIH), we conducted a propensity matching study to assess the efficacy and safety of MMF vs. AZA.MethodsAll 126 conse...

Full description

Bibliographic Details
Main Authors: George N. Dalekos, Pinelopi Arvaniti, Nikolaos K. Gatselis, Anna Samakidou, Stella Gabeta, Eirini Rigopoulou, George K. Koukoulis, Kalliopi Zachou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
autoimmune hepatitis
autoimmune liver diseases
mycophenolate mofetil
azathioprine
immunosuppression
outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.798602/full

Similar Items

Similar Items